FIELD: medicine, pharmaceutics.
SUBSTANCE: inventions deal with a membrane, used as a substrate for growing cells of retinal pigment epithelium, its application for supporting cells and a method of inoculating the cells on such a membrane. The characterised membrane is non-biodegradable and porous, covered from at least one side with a glycoprotein-containing coating, with pores with a diameter approximately from 0.2 mcm to 0.5 mcm, with a density of membrane pores constituting approximately from 1×107 to 3×108 pores per 1 cm2, and hydraulic conductivity of the membrane higher than 50×10-10 m sec-1 Pa-1, and having the maximal thickness of 11 mm.
EFFECT: claimed inventions make it possible to obtain a transplant for treatment of age-related macular degeneration.
19 cl, 4 dwg, 6 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF CELL CO-CULTIVATION FOR FORMATION OF AN IN VITRO MODEL OF THE HEMATOENCEPHALIC BARRIER | 2019 |
|
RU2724956C1 |
| METHOD FOR CELL CRYOPRESERVATION, ARTIFICIAL CELL CONSTRUCTS OR THREE-DIMENSIONAL TISSUE COMPLEXES | 2010 |
|
RU2573307C2 |
| SINGLE EMBRYO STEM CELL CULTURE | 2008 |
|
RU2473687C2 |
| METHOD FOR CELL SHEET PRODUCTION FROM RETINAL PIGMENT EPITHELIAL CELLS | 2012 |
|
RU2628697C2 |
| USING LAMININ IN CORNEAL ENDOTHELIAL CELL CULTURE | 2014 |
|
RU2704984C1 |
| METHODS OF ISOLATING AND CULTIVATING HUMAN RETINAL PROGENITOR CELLS | 2019 |
|
RU2809003C2 |
| METHOD FOR PLURIPOTENT STEM CELLS DIFFERENTIATION INTO VASCULAR BED CELLS | 2012 |
|
RU2618871C2 |
| METHOD FOR OBTAINING ENDOTHELIOCYTES FROM HUMAN EMBRYONIC STEM CELLS (VERSIONS) | 2008 |
|
RU2359030C1 |
| METHODS AND COMPOSITIONS FOR CELL FIXATION AND CULTURE ON FLAT CARRIERS | 2009 |
|
RU2547925C2 |
| TWO-LAYER, FLAT, TRANSPARENT HYDROGEL SUBSTRATE FOR LONG-TERM CELL CULTIVATION | 2016 |
|
RU2614260C1 |
